{"id":31340,"date":"2026-07-29T11:54:23","date_gmt":"2026-07-29T09:54:23","guid":{"rendered":"https:\/\/www.neolifesalud.com\/blog\/uncategorized\/vitamin-d-an-evidence-based-cornerstone-of-healthy-aging\/"},"modified":"2026-07-29T11:54:23","modified_gmt":"2026-07-29T09:54:23","slug":"vitamin-d-an-evidence-based-cornerstone-of-healthy-aging","status":"publish","type":"post","link":"https:\/\/www.neolifesalud.com\/en\/blog\/supplementation\/vitamin-d-an-evidence-based-cornerstone-of-healthy-aging\/","title":{"rendered":"Vitamin D: An Evidence-Based Cornerstone of Healthy Aging"},"content":{"rendered":"
\n

Vitamin D3 supplementation, including doses of up to 4,000 IU\/day in selected patients, has emerged as a safe and effective strategy to correct deficiency and preserve musculoskeletal health during aging.<\/strong><\/h1>\n

Vitamin D deficiency remains highly prevalent, even in Mediterranean countries. The latest evidence supports an individualized approach to supplementation, highlighting that doses of up to 4,000 IU\/day may be necessary to achieve optimal 25(OH)D concentrations in certain patients. Beyond its well-established role in bone metabolism, vitamin D is increasingly recognized as an important contributor to healthy aging. <\/p>\n

Dr. Mireia Junyent \u2013 Neolife Medical Team <\/em><\/p>\n

\n

Why Is Vitamin D Deficiency Still So Common?<\/strong><\/p>\n

Despite the abundant sunlight typical of Mediterranean regions, vitamin D<\/strong> insufficiency continues to represent a significant public health issue. A substantial proportion of adults have inadequate 25-hydroxyvitamin D levels, particularly older adults, individuals with obesity, gastrointestinal disorders, limited sun exposure, or darker skin phototypes. <\/p>\n

Aging<\/strong> reduces the skin’s ability to synthesize vitamin D, increasing the risk of chronic insufficiency that may negatively affect musculoskeletal health and physical function.<\/p>\n

Recent meta-analyses consistently show that conventional supplementation doses (600\u2013800 IU\/day) may be insufficient to achieve adequate serum levels in patients with risk factors, reinforcing the importance of personalized supplementation<\/strong> strategies.<\/p>\n

\"VitD3\"<\/p>\n

4,000 IU\/Day: An Evidence-Based Dose<\/strong><\/p>\n

Current recommendations emphasize that the optimal vitamin D dose should be tailored to each individual’s characteristics. Multiple clinical trials and systematic reviews have demonstrated that supplementation with 4,000 IU\/day of cholecalciferol <\/strong>(vitamin D3) is more effective at correcting vitamin D<\/strong> deficiency than standard doses, particularly in patients with obesity, older age, or malabsorption. <\/p>\n

This regimen has been shown to provide:<\/p>\n